ARAMIS BIOSCIENCES

aramis-biosciences-logo

Aramis Biosciences provides disease-modifyingย therapy for ocular surface disease and is an immuno-ophthalmology biopharmaceutical company. For inquiries, email, telephone numbers, and physical addresses are available on their website.

#SimilarOrganizations #People #Financial #Website #More

ARAMIS BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2018-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.aramisbio.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
U.S. Server Location


Similar Organizations

asana-biosciences-logo

Asana BioSciences

Asana BioSciences is a clinical-stage biopharmaceutical company.

century-therapeutics-logo

Century Therapeutics

Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

peroxitech-therapeutics-logo

Peroxitech Therapeutics

Peroxitech Therapeutics operates as a biopharmaceutical company.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

saol-therapeutics-logo

Saol Therapeutics

Saol Therapeutics is a biotech pharmaceutical company.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

vicardia-logo

ViCardia

ViCardia is a clinical-stage biopharmaceutical company.


Current Advisors List

not_available_image

Sunil Chauhan Co-Founder and Board Member @ Aramis Biosciences
Board_member
2018-01-01

Current Employees Featured

david-s-tierney_image

David S. Tierney
David S. Tierney President and CEO @ Aramis Biosciences
President and CEO
2020-12-01

reza-dana_image

Reza Dana
Reza Dana Scientific Co-Founder @ Aramis Biosciences
Scientific Co-Founder
2018-11-01

Founder


reza-dana_image

Reza Dana

not_available_image

Sunil Chauhan

Investors List

safar-partners-7ab4_image

Safar Partners

Safar Partners investment in Seed Round - Aramis Biosciences

Official Site Inspections

http://www.aramisbio.com Semrush global rank: 8.13 M Semrush visits lastest month: 643

Unable to get host informations!!!

Loading ...

More informations about "Aramis Biosciences"

About - Aramis Biosciences

Aramis Biosciences was founded in 2018 following more than a decade of research at The Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, where the role of a โ€ฆSee details»

Contact - Aramis Biosciences

Organization Message Thank you for your message. Submit Aramis Biosciences 266 Main Street, Building 2, Suite 11 Medfield, MA 02052 Additional Inquires can be sent to the following: โ€ฆSee details»

Aramis Biosciences - Crunchbase Company Profile & Funding

Aramis Biosciences provides disease-modifying therapy for ocular surface disease and is an immuno-ophthalmology biopharmaceutical company. For inquiries, email, telephone numbers, โ€ฆSee details»

Aramis Biosciences - PitchBook

Information on valuation, funding, cap tables, investors, and executives for Aramis Biosciences. Use the PitchBook Platform to explore the full profile.See details»

Aramis Biosciences - LinkedIn

Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface disease.See details»

Aramis Biosciences - Overview, News & Similar companies

Jan 10, 2022 Who is Aramis Biosciences. Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease โ€ฆSee details»

Aramis Biosciences - VentureRadar

"Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface disease.See details»

Aramis Biotechnologies | Plant-based vaccine technology

Notre technologie . En sโ€™appuyant sur la capacité unique des cellules végétales, Aramis Biotechnologies développe une nouvelle génération de plateforme de biofabrication dans les plantes pour répondre aux besoins de santé publique โ€ฆSee details»

Aramis Biosciences Overview | SignalHire Company Profile

Organization Website: aramisbio.com : Aramis Biosciences industries Biotech: Headquarters Location: Boston, MA, US Boston, MA, US : Aramis Biosciences Employees Size 1-10 โ€ฆSee details»

Aramis Biosciences Launches to Address Unmet Needs in Ocular โ€ฆ

Dec 15, 2021 [email protected]. For inquiries on Dompé farmaceutici and EXSCALATE: Guido Romeo โ€“ Head Corporate Communications Mob. +39 349 4154010 โ€ฆSee details»

Aramis Biosciences - workinbiotech.com

Aramis Biosciences is concentrated on creating novel disease-modifying treatments for dry eye disease, which is highly undertreated. They are a Massachusetts-based clinical-stage โ€ฆSee details»

Corporate culture - Aramis Biotechnologies

Our Vision and Mission Our vision is to become the world leader in the manufacturing of plant-based vaccines and our mission is to sustainably address the world's human health needs. By โ€ฆSee details»

Biotechnologies Aramis Inc - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Biotechnologies Aramis Inc of Québec, QC. Get the latest business insights from Dun & โ€ฆSee details»

Aramis Biotechnologies | Plant-based vaccine technology

Our technology . Drawing on the unique capacity of plant cells, Aramis Biotechnologies is developing a new generation of biomanufacturing platforms in plants to meet current public โ€ฆSee details»

Aramis Biosciences Announces First Patient Dosed in Phase II โ€ฆ

Feb 28, 2022 โ€œWe are thrilled with the study team assembled for this clinical trial, from our contract research organization to our clinical investigators, and look forward to topline proof of โ€ฆSee details»

Aramis Biotechnologies and the Biologics Manufacturing Centre โ€ฆ

Feb 14, 2025 Agreement on Formulation and Finish of a Virus-Like Particle Vaccine for Phase 1 and 2 Clinical Trials. Montreal and Quebec City, February 14, 2025 โ€“ Aramis Biotechnologies โ€ฆSee details»

Aramis Biosciences Launches to Address Unmet Needs in Ocular โ€ฆ

Dec 16, 2021 (PRESS RELEASE) BOSTON, MA โ€” Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the โ€ฆSee details»

Aramis Biosciences Announces First Patient Dosed in Phase

BOSTON, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced that the first patient โ€ฆSee details»

Pipeline - Aramis Biosciences

Pipeline Aramis Biosciences was founded to revolutionize the standard of care in ocular immunology, beginning with Dry Eye Disease.See details»

Aramis Biotechnologies secures $80M CAD to relaunch Plant โ€ฆ

Dec 9, 2024 A Second Chance for Plant-Based Vaccines. Aramis Biotechnologies was founded in 2023 by former employees of Medicago, a failed biotech firm shuttered by Mitsubishi โ€ฆSee details»

linkstock.net © 2022. All rights reserved